Probity Advisors Inc. Takes $304,000 Position in Phreesia, Inc. (NYSE:PHR)

Probity Advisors Inc. acquired a new stake in Phreesia, Inc. (NYSE:PHR - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 12,074 shares of the company's stock, valued at approximately $304,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of PHR. Invesco Ltd. increased its stake in Phreesia by 0.9% in the 4th quarter. Invesco Ltd. now owns 40,249 shares of the company's stock worth $1,013,000 after buying an additional 357 shares in the last quarter. NewEdge Advisors LLC lifted its stake in Phreesia by 12.1% in the fourth quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock worth $107,000 after purchasing an additional 459 shares during the last quarter. Johnson Financial Group Inc. increased its position in shares of Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock worth $28,000 after acquiring an additional 896 shares during the period. R Squared Ltd purchased a new position in shares of Phreesia during the fourth quarter worth approximately $30,000. Finally, BankPlus Trust Department purchased a new position in Phreesia during the fourth quarter valued at approximately $34,000. 92.10% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on PHR shares. Truist Financial lifted their price target on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday. Citigroup restated a "buy" rating on shares of Phreesia in a research report on Wednesday. KeyCorp decreased their price objective on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. DA Davidson cut their target price on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Finally, Needham & Company LLC reissued a "buy" rating and set a $29.00 target price on shares of Phreesia in a research note on Thursday, March 13th. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia presently has an average rating of "Buy" and a consensus target price of $31.64.

Insider Activity at Phreesia

In other news, SVP David Linetsky sold 4,499 shares of the stock in a transaction that occurred on Wednesday, April 16th. The shares were sold at an average price of $23.73, for a total value of $106,761.27. Following the completion of the sale, the senior vice president now directly owns 217,239 shares of the company's stock, valued at $5,155,081.47. This represents a 2.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Evan Roberts sold 1,845 shares of the firm's stock in a transaction on Wednesday, April 16th. The stock was sold at an average price of $23.81, for a total transaction of $43,929.45. Following the completion of the sale, the chief operating officer now owns 774,807 shares in the company, valued at approximately $18,448,154.67. The trade was a 0.24% decrease in their position. The disclosure for this sale can be found here. Insiders sold 42,474 shares of company stock worth $1,023,208 in the last 90 days. Corporate insiders own 5.50% of the company's stock.

Phreesia Stock Up 0.5%

Shares of PHR stock traded up $0.12 on Friday, hitting $24.55. The stock had a trading volume of 672,417 shares, compared to its average volume of 440,425. The firm has a market capitalization of $1.46 billion, a price-to-earnings ratio of -16.70 and a beta of 0.74. The stock's 50 day moving average is $24.80 and its 200-day moving average is $25.31. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53.

Phreesia (NYSE:PHR - Get Free Report) last issued its earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company had revenue of $115.94 million for the quarter, compared to analysts' expectations of $115.00 million. During the same period in the prior year, the company earned ($0.05) earnings per share. The firm's revenue was up 14.5% compared to the same quarter last year. As a group, research analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.